Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 2, 2007, Pages 280-287

  Müller, Joachim ^a   Sterk, Maaike ^a   Hemphill, Andrew ^a   Müller, Norbert ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLOROMERCURIBENZOIC ACID; BACITRACIN; INSULIN; MEMBRANE PROTEIN; METRONIDAZOLE; NITAZOXANIDE; NITROREDUCTASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE 2; PROTEIN DISULFIDE ISOMERASE 4; PYRUVATE SYNTHASE; PYRUVATE SYNTHASE 1; PYRUVATE SYNTHASE 2; TIZOXANIDE; UNCLASSIFIED DRUG; VARIANT SURFACE PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE EXPRESSION; GIARDIA LAMBLIA; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; TROPHOZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; CLONE CELLS; DNA PRIMERS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GIARDIA LAMBLIA; METRONIDAZOLE; PROTEIN DISULFIDE-ISOMERASE; PYRUVATE OXIDASE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; THIAZOLES;

EID: 34547828244     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm205     Document Type: Article

References (37)

1. Upcroft J, Upcroft P. My favourite cell. Giardia BioEssays 1998; 20: 256-63.
2. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001; 14: 114-28.
3. Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001; 14: 150-64.
4. Homer DS, Hirt RP, Embley TM. A single eubacterial origin of eukaryotic pyruvate:fErredoxin oxidorIductase genes: implications for the evolution of anaerobic eukaryotes. Mol Biol Evol 1999; 16: 1280-91.
5. Upcroft JA, Dunn LA, Wright JM et al. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob Agents Chemother 2006; 50 344-7.
6. Upcroft JA, Upcroft P. Drug resistance and Giardia. Parasitol Today 1993; 9: 187-90.
7. Townson SM, Upcroft JA, Upcroft P. Characterisation and purification of pyruvate:fErredoxin oxidoreductase from Giardia duodenalis. Mol Biochem Parasitol 1996; 79: 183-93.
8. Fox LM, Saravolatz LD. Nitazoxanide: A new thiazolide antiparasitic agent. Clin Infect Dis 2005; 40: 1173-80.
9. Hemphill A, Müller J, Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 2006; 7: 953-64.
10. Adagu IS, Nolder D, Warhurst D et al. In vitro activity of nitazoxanide related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother 2002; 49: 103-11.
11. Gilles HM, Hoffman PS. Treatment of intestinal parasitic infections: A review of nitazoxanide. Trends Parasitol 2002; 18: 95-7.
12. White CA Jr. Nitazoxanide: A new broad spectrum antiparasitic agent. Expert Rev Anti-Infect Ther 2004; 2: 43-9.
13. Müller J, Rühle G, Müller N et al. In vitro effects of thiazolides on Giardia lamblia WB C6 cultured axenically and in co-culture with Caco2 cells. Antimicrob Agents Chemother 2006; 50: 162-70.
14. Wright JM, Dunn LA, Upcroft P et al. Efficacy of antigiardial drugs. Expert Opin Drug Saf 2003; 2: 529-41.
15. Pankuch GA, Appelbaum PC. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species. Antimicrob Agents Chemother 2006; 50 1112-7.
16. Hoffman PS, Sisson G, Croxen MA et al. Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori and selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother 2007; 51: 868-76.
17. Cortes HCE, Müller N, Esposito M et al. In vitro efficacy of nitro-and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besrioitia besnoiti infection in Vero cells. Parasitology 2007, in press.
18. Knodler L, Noiva R, Mehta K. Novel protein-disulfide isomerases from the early-diverging protist Giardia lamblia. J Biol Chem 1999; 274 29805-11.
19. Müller N, Gottstein B. Antigenic variation the murine immune response to Giardia lamblia. Int J Parasitol 1998; 28: 1829-39.
20. Müller N, von Allmen N. Recent insights into the mucosal reactions associated with Giardia lamblia infections. Int J Parasitol 2005; 35: 1339-47.
21. Hehl AB, Marti M. Secretory protein trafficking in Giardia intestinalis. Mol Microbiol 2004; 53: 19-28.
22. Rasoloson D, Vanacova S, Tomkova E et al. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Microbiology 2002; 148: 2467-77.
23. Megraud F, Occhialini A, Rossignol J-F. Nitazoxanide: A potential drug for eradication of Helicobacter pilori with no cross-resistance to metronidazole. Antimicrob Agents Chemother 1998; 42: 2836-40.
24. Von Allmen N, Bienz M, Hemphill A et al. Experimental infections of neonatal mice with cysts of Giardia lamblia clone GS/M-83-H7 are associated with an antigenic reset of the parasite. Infect Immun 2004; 72: 4763-71.
25. Nash TE, Mowatt MR. Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size. Mol Biochem Parasitol 1992; 51: 219-28.
26. Lundstrom J, Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem 1990; 265: 9114-20.
27. Smith A, Chan J, Oksenberg D et al. A high-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity. J Biomol Screen 2004; 9: 614-20.
28. Cruz A, Sousa MJ, Azeredo, Z et al. Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole. J Antimicrob Chemother 2003; 51: 1017-20.
29. Khan IA, Avery MA, Burandt CL et al. Antigiardial activity of isoflavones from Dalbergia frutescens bark. J Nat Prod 2000; 63: 1414-6.
30. Mandel R, Ryser HJP, Ghani F et al. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide Isomerase. Proc Natl Acad Sci USA 1993; 90 4112-6.
31. Guttner Y, Windsor HM, Viiala CH et al. Nitazoxanide in treatment of Helicobacter pylori a clinical and in vitro study. Antimidrob Agents Chemother 2003; 47: 3780-3.
32. Samuelson J. Why metronidazole is active against both bacteria parasites. Antimicrob Agents Chemother 1999; 3: 1533-41.
33. Sisson G, Goodwin A, Raudonikiene A et al. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pilori. Antimicrob Agents Chemother 1999; 46: 2116-23.
34. Buchanan BB, Balmer Y. Redox regulation: A broadening horizon. Annu Rev Plant Biol 2005; 56: 187-220.
35. Frickel E-M, Frei P, Bouvier M et al. ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem 2004; 279: 18277-87.
36. Jiang X-M, Fitzgerald M, Chris M et al. redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J Biol Chem 1999; 274: 2416-23.
37. Kulakova L, Singer SM, Conrad J et al. Epigenetic mechanisms are involved in the control of Giardia lamblia antigenic variation. Mol Microbiol 2006; 61: 1533-42.